Manufacturing

Procter & Gamble is creating a new R&D facility for subsidiary firm Gillette in South Boston. Representing an investment of nearly $1 billion, the nine-story building with feature the Technical Innovation Center as well as serving as the headquarters for Gillette's grooming business. The 324,315-sf structure was designed by Payette as an integrated destination for research, engineering, product development, and administration, uniting operations currently spread over the company’s 31-acre campus.

From cortisone to CAT scans, the future of medicine has often arrived first at the Mayo Clinic. The tradition continues today with the fit-up of a new headquarters for regenerative biotherapeutics adjacent to the research center’s Rochester, Minn., campus. The fourth floor of the recently built Discovery Square building, Two Discovery Square, had been earmarked originally for office space, but after COVID hit, the developer offered the opportunity to convert some of the office space to laboratory space. Mayo Clinic had been planning to build a Center for Regenerative Biotherapeutics and saw an opportunity to lease the 18,000-sf space at Discovery Square and convert it for this cutting-edge biomanufacturing facility.  

Clemson University opened the Advanced Materials Innovation Complex in February of 2026 in Clemson, S.C. The $130 million building is the university's most technologically advanced facility to date and will enable the workforce of the future to gain hands-on experience in next-generation manufacturing processes.

Micron broke ground in January of 2026 on a $100 billion complex for the creation of advanced memory chips in Clay, N.Y. With up to four fabs, the development will be the largest semiconductor facility in the United States and represents the largest private investment in the state's history. The visionary campus will leverage groundbreaking technologies to meet the growing demands of AI systems and devices, driving economic growth and accelerating innovation.

Eli Lilly and Company is planning to construct an advanced manufacturing facility in Huntsville, Ala. Representing a total investment of $6 billion, the multibuilding campus will offer over 1 million sf of space for production, laboratories, packaging, logistics, and utilities. The sophisticated development will manufacture active pharmaceutical ingredients and small molecule synthetic and peptide medicines, including the company’s first oral small molecule GLP-1 receptor agonist, orforglipron.

Cabot, Cabot & Forbes broke ground in November of 2025 on an innovation, manufacturing, and research hub in Woburn, Mass. Developed from the former Industri-Plex Superfund site, The Bolt will offer leading-edge laboratory and office space for companies engaged in a wide range of sectors, including life sciences, biotechnology, energy, advanced manufacturing, and technology. 

Amkor Technology broke ground in October of 2025 on an advanced packaging and testing campus for semiconductors in Peoria, Ariz. Strategically located in the state’s growing innovation corridor, the two-phase project will offer over 750,000 sf of cleanroom space upon completion. The sophisticated hub will feature smart factory technologies and scalable production lines to meet evolving market demands for artificial intelligence (AI) and high-performance computing, as well as mobile communications and automotive applications. 

Eli Lilly and Company is constructing the $4.5 billion Lilly Medicine Foundry in Lebanon, Ind. The 1.2 million-sf center will combine research and advanced manufacturing with the latest technology to innovate new production methods and scale global access to medicines for clinical trials. Featuring a flexible layout, the seven-building complex will create various molecular therapies, including drug substances for small molecules, biologics, and nucleic acid therapeutics. 

Merck opened a filter and membrane manufacturing facility in October of 2025 in Cork, Ireland. Offering 32,291 sf of cleanroom space, the €150 million ($174.5 million) building will meet global demand in the production process of vaccines and life-changing biomedical treatments, including monoclonal antibodies and cell and gene therapies. By locating these expanded manufacturing capacities in Europe, Merck aims to reduce cross-border dependencies and ensure reliable access to critical filtration technologies.

FUJIFILM Biotechnologies opened a $3.2 billion pharmaceutical manufacturing facility in September of 2025 in Holly Springs, N.C. Integrating leading-edge equipment and technologies, the sophisticated development features eight 20,000-liter bioreactors for the production of bulk drug substances and innovative therapies. Johnson & Johnson and Regeneron have signed 10-year contracts to secure space at the 1.3 million-sf campus, which represents the largest end-to-end cell culture CDMO hub in North America. 

The University of Pittsburgh is constructing the state-of-the-art BioForge center in the Hazelwood Green development, a brownfield site site that once accommodated a steel mill. Designed by HOK, the $250 million hub will drive breakthroughs and innovations in the manufacturing of precision biological medicines to improve human health. The 185,000-sf building will fill a critical gap in the local biotechnology ecosystem by addressing production constraints and cost-based obstacles to the wide distribution and accessibility of novel treatments.

Nokia unveiled a state-of-the-art campus for R&D and manufacturing in September of 2025 in Oulu, Finland. Spanning 592,015 sf, this dynamic innovation hub will design, test, and deliver 5G and 6G radio networks built for artificial intelligence. The bipartite project comprises eight floors of flexible office space and a two-story factory for industrial production. Laboratories equipped with advanced technologies provide both simulated and real-world field verification environments to accelerate network evolution.

Designing and building labs in the unlikely and constrained location of the prestigious Pacific Design Center (PDC) with Hollywood as a backdrop is a daunting task, requiring adherence to quality expectations, facilities management guidelines in a non-research environment, separation from existing high-end tenants, and compliance with infrastructure requirements. Cedars-Sinai, one of the largest nonprofit medical centers in the U.S., accepted the challenge after deciding to expand its research portfolio. Growing beyond its limited campus is necessary to accommodate the rapid growth of its research facilities and to aid in recruiting top scientists by providing innovative facilities with optimum resources. Hospital officials looked a half mile from their campus to the PDC, a designated cultural resource building complex designed by Cesar Pelli in the 1970s. Known in the 1980s and 1990s as a vibrant hub of premier art, design, and architectural showrooms, many of the tenants now have online shops rather than physical space in the cluster of buildings, leaving vacancies available for lease and an opportunity for Cedars-Sinai’s growth.

Savannah River National Laboratory opened the Advanced Manufacturing Collaborative (AMC) in August of 2025 on the campus of the University of South Carolina Aiken. Designed by STOA Architects and Page (now part of Stantec), the $66 million facility will enable the Department of Energy’s Office of Environmental Management to engage in collaborative discovery with academic institutions, industry partners, and government agencies at the city, state, and federal level. 

GenesisM, a joint venture between Bain Capital and Botanic Properties, broke ground on a Class A biomanufacturing facility in July of 2025 in Bedford, Mass. Designed by Perkins&Will, the sophisticated development addresses a critical need for purpose-built life sciences infrastructure in the Greater Boston region.